<DOC>
	<DOCNO>NCT01010932</DOCNO>
	<brief_summary>The study evaluate efficacy safety Dotarem enhance MRA patient suffer carotid vertebral arterial disease .</brief_summary>
	<brief_title>Carotid Vertebral Magnetic Resonance Angiography ( MRA ) Study Comparing Dotarem Time Of Flight ( TOF )</brief_title>
	<detailed_description>Each subject undergo Time Of Flight ( TOF ) Magnetic Resonance Angiography ( MRA ) follow Dotarem enhance MRA .</detailed_description>
	<mesh_term>Cerebral Arterial Diseases</mesh_term>
	<criteria>Male female , age 18 year Strongly suspect carotid vertebral arterial disease Scheduled ( schedule ) undergo compute tomography angiography ( CTA ) examination Known grade IV V chronic kidney disease ( GFR &lt; 30 mL/min/1.73m² ) Contraindication MRI Acute renal dysfunction within 6 month precede Dotarem®enhanced MRA examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>carotid vertebral artery disease</keyword>
	<keyword>Contrast agent</keyword>
	<keyword>MRA</keyword>
</DOC>